Published in N Engl J Med on December 23, 1999
Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol (2009) 2.49
Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol (2007) 1.77
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol (2009) 1.40
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years. J Am Heart Assoc (2014) 1.19
Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008. PLoS One (2011) 1.14
Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med (2000) 1.00
Adjuvant revascularization of intracranial artery occlusion with angioplasty and/or stenting. Neuroradiology (2008) 0.99
Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart (2005) 0.98
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures. CMAJ (2002) 0.97
Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart (2001) 0.96
Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention. World J Cardiol (2015) 0.95
Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol (2010) 0.90
Myocardial contrast echocardiography for predicting functional recovery after acute myocardial infarction. Int J Cardiovasc Imaging (2002) 0.89
Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg (2008) 0.85
Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells. Tex Heart Inst J (2010) 0.85
Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology (2006) 0.84
Recent advances in primary percutaneous intervention for acute myocardial infarction. Heart (2005) 0.82
Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction. Heart Vessels (2008) 0.81
Imaging microvascular obstruction and its clinical significance following acute myocardial infarction. Heart Fail Rev (2006) 0.81
Perfusion assessed by real-time contrast echocardiography correlates with clinical and echocardiographic parameters in patients with first STEMI treated with PCI - 6-month follow-up. Arch Med Sci (2010) 0.80
Clinical safety of cardiac magnetic resonance imaging at 3 T early after stent placement for acute myocardial infarction. Eur Radiol (2009) 0.79
A study of cognitive dysfunction in patients having carotid endarterectomy performed with regional anesthesia. Anesth Analg (2008) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
Mechanical reperfusion therapy for acute myocardial infarction: Stent PAMI, ADMIRAL, CADILLAC and beyond. Heart (2002) 0.79
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight. Curr Control Trials Cardiovasc Med (2001) 0.79
Coronary stents--have they fulfilled their promise? N Engl J Med (1999) 0.79
Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation. Exp Ther Med (2013) 0.78
Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction. Heart (2013) 0.78
Acute coronary syndrome: ST segment elevation myocardial infarction. BMJ (2003) 0.78
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty? Curr Control Trials Cardiovasc Med (2000) 0.77
Thrombus aspiration in acute myocardial infarction: Rationale and indication. World J Cardiol (2014) 0.77
Thrombolysis: past, present, and future. Postgrad Med J (2006) 0.76
Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-elevation myocardial infarction: the impact of distal embolisation. Neth Heart J (2002) 0.76
Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging (2004) 0.76
Acute myocardial infarction: primary angioplasty. Heart (2001) 0.76
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction. Int J Angiol (2012) 0.76
Cardiac magnetic resonance imaging safety following percutaneous coronary intervention. Int J Cardiovasc Imaging (2013) 0.76
Myocardial salvage for ST-elevation myocardial infarction with terminal QRS distortion and restoration of brisk epicardial coronary flow. Heart Vessels (2009) 0.75
Coronary-artery stenting in acute myocardial infarction. N Engl J Med (2000) 0.75
Management of multivessel coronary disease after primary angioplasty: staged reintervention versus optimized clinical treatment and two-year follow-up. Rev Bras Cir Cardiovasc (2014) 0.75
Very late hazard with stenting versus balloon angioplasty for ST-elevation myocardial infarction: a 16-year single-center experience. J Interv Cardiol (2013) 0.75
Reperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now. BMJ (2000) 0.75
Coronary-artery stenting in acute myocardial infarction. N Engl J Med (2000) 0.75
High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction. Int J Clin Exp Med (2015) 0.75
Determining microvascular obstruction and infarct size with steady-state free precession imaging cardiac MRI. PLoS One (2015) 0.75
Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty. Can J Cardiol (2008) 0.75
Coronary-artery stenting in acute myocardial infarction. N Engl J Med (2000) 0.75
Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases. J Geriatr Cardiol (2015) 0.75
No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction. Chonnam Med J (2016) 0.75
Quantified coronary frequency domain optical coherence tomography signal analysis for the evaluation of erythrocyte-rich thrombus: ex-vivo validation study. Int J Cardiovasc Imaging (2016) 0.75
Unmet goals in the treatment of Acute Myocardial Infarction: Review. F1000Res (2017) 0.75
Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model. Heart Vessels (2017) 0.75
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1993) 6.52
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
The product of a newly identified gene, gInF, is required for synthesis of glutamine synthetase in Salmonella. Proc Natl Acad Sci U S A (1977) 5.19
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med (1997) 4.88
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol (1995) 4.10
Improvement of retardates' mealtime behaviors by timeout procedures using multiple baseline techniques. J Appl Behav Anal (1970) 3.97
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med (2001) 3.85
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (1991) 3.56
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol (2000) 2.99
Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv (2000) 2.94
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med (2001) 2.83
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Searching for autolysin functions. Characterization of a pneumococcal mutant deleted in the lytA gene. Eur J Biochem (1986) 2.58
The training and generalization of a conversational speech form in nonverbal retardates. J Appl Behav Anal (1974) 2.55
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med (2001) 2.54
Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol (1992) 2.50
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Coronary artery anomalies: a review of more than 10,000 patients from the Clayton Cardiovascular Laboratories. Tex Heart Inst J (1988) 2.48
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv (2000) 2.42
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation (2001) 2.22
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med (1999) 2.19
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol (2000) 2.12
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
The problem of arteria lusoria in right transradial coronary angiography and angioplasty. Catheter Cardiovasc Interv (2001) 1.92
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation (2001) 1.91
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation (2004) 1.76
Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative. Antimicrob Agents Chemother (1979) 1.75
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol (2001) 1.74
Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn (1994) 1.68
The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci (1996) 1.65
Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J (2001) 1.61
The clinical syndrome of atrial myxoma. JAMA (1974) 1.60
Early systolic closure of the aortic valve in patients with hypertrophic subaortic stenosis and discrete subaortic stenosis. Correlation with preoperative and postoperative hemodynamics. Am J Cardiol (1978) 1.60
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin (2010) 1.59
[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn (1996) 1.54
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J (1994) 1.53
Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). Am J Cardiol (2001) 1.50
Feasibility of routine transradial coronary angiography: a single operator's experience. J Invasive Cardiol (1999) 1.49
Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J Am Coll Cardiol (1989) 1.48
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Successful treatment of a saphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv (1999) 1.47
Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn (1997) 1.47
Aortocoronary saphenous vein bypass. Results in 1,492 patients, with particular reference to patients with complicating features. Ann Thorac Surg (1973) 1.47
Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. Am Heart J (2000) 1.47
Late results of percutaneous transluminal coronary angioplasty of two or more major native coronary arteries. Am J Cardiol (1994) 1.46
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res (1996) 1.45
Coronary angiography using 4 or 6 French diagnostic catheters: a prospective, randomized study. J Invasive Cardiol (2001) 1.45
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) Circulation (1998) 1.45
Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn (1998) 1.45
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA) Cathet Cardiovasc Diagn (1998) 1.44
Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol (1995) 1.43
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Amplatzing a 6 Fr Judkins right guiding catheter for increased success in complex right coronary artery anatomy. Catheter Cardiovasc Interv (2001) 1.43
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Death with dipyridamole-thallium imaging. Ann Intern Med (1988) 1.42
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1996) 1.41
Coronary thrombosis during acute myocardial infarction: Roberts was right! Am J Cardiol (1998) 1.41
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther (2001) 1.41
Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.40
Coronary angioplasty using 5 French guiding catheters: preliminary experience. Catheter Cardiovasc Interv (2000) 1.40
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med (1988) 1.39
Emergency coronary stenting for acute occlusive dissection of the left main coronary artery. Cathet Cardiovasc Diagn (1993) 1.39
Percutaneous triple-valve balloon valvuloplasty in a pregnant woman. Cathet Cardiovasc Diagn (1991) 1.39
Transradial cardiac catheterization in patients with prior brachial artery cutdown. Catheter Cardiovasc Interv (1999) 1.39
FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol (2000) 1.39
Transradial cardiac catheterization in elderly patients. Catheter Cardiovasc Interv (2000) 1.39
Predictors of short term clinical and angiographic outcome after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn (1995) 1.39
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
[Coronary angioplasty in patients with restenosis. Characterization of clinical and angiographic profiles, hospital clinical course, and implications for the selection of patients]. Arq Bras Cardiol (1995) 1.39